Zacks Investment Research
19 May 2026, 14:55 UTC · 25w ago
Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade
Verdict
Headline leans bullish. We score CADL +0.80 across two claims.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · CADL
+0.80strongly bullish




